The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome (NCT04721522) | Clinical Trial Compass
UnknownNot Applicable
The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome
Egypt356 participantsStarted 2021-01-29
Plain-language summary
Absence of endometrial compaction on the day of ET has adverse effects on success of ART outcome.
Who can participate
Age range18 Years – 37 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All women should have the following:
Aged from 18 - 37 years old. Undergoing fresh ICSI cycles. A normal uterus with no anomalies or pathologies. At least one good-quality embryo/blastocyst available for transfer (3 BB and more according to Gardner and Schoolcraft grading system).
Easy mockup embryo transfer (i.e. the catheter is smoothly inserted without touching the fundus, no cervix tenaculum is used and the catheter is clean of blood).
Exclusion Criteria:
\- Younger than 18 or older than 37 years old. Congenital uterine abnormality or pathology. Presence of a hydrosalpinx. Chronic diseases which are not suitable for pregnancy. ICSI cycles with fresh or frozen TESE samples.
What they're measuring
1
whether the occurrence of endometrial compaction on the day of embryo transfer has a role in optimizing ongoing pregnancy rate in ART cycles